日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Targeting of CD38 by the Tumor Suppressor miR-26a Serves as a Novel Potential Therapeutic Agent in Multiple Myeloma

肿瘤抑制因子 miR-26a 靶向 CD38 可作为多发性骨髓瘤的新型潜在治疗剂

Yi Hu #, Huimin Liu #, Chuanfeng Fang, Chen Li, Fjorela Xhyliu, Hayley Dysert, Juraj Bodo, Gabriel Habermehl, Benjamin E Russell, Wenjun Li, Marcia Chappell, Xiaofeng Jiang, Sarah L Ondrejka, Eric D Hsi, Jaroslaw P Maciejewski, Qing Yi, Kenneth C Anderson, Nikhil C Munshi, Geyou Ao, Jason N Valent, 

Real-world data on safety and efficacy of venetoclax-based regimens in relapsed/refractory t(11;14) multiple myeloma

维奈托克方案治疗复发/难治性t(11;14)多发性骨髓瘤的真实世界安全性和有效性数据

Basali, Diana; Chakraborty, Rajshekhar; Rybicki, Lisa; Rosko, Nathaniel; Reed, Janice; Karam, Maryann; Schlueter, Kristen; Dysert, Hayley; Kalaycio, Matt; Valent, Jason

Characterisation and prognostic impact of immunoparesis in relapsed multiple myeloma

复发性多发性骨髓瘤中免疫麻痹的特征及其预后影响

Chakraborty, Rajshekhar; Rybicki, Lisa; Nakashima, Megan O; Dean, Robert M; Faiman, Beth M; Samaras, Christy J; Rosko, Nathaniel; Dysert, Hayley; Valent, Jason; Anwer, Faiz

Care delivery and compensation system changes: a case study of organizational readiness within a large dental care practice organization in the United States

医疗服务提供和补偿体系变革:美国大型牙科诊所组织组织准备情况案例研究

Cunha-Cruz, Joana; Milgrom, Peter; Huebner, Colleen E; Scott, JoAnna; Ludwig, Sharity; Dysert, Jeanne; Mitchell, Melissa; Allen, Gary; Shirtcliff, R Mike

A history of pathology and laboratory medicine at Baylor University Medical Center

贝勒大学医学中心病理学和实验室医学史

Race, George J; Tillery, G Weldon; Dysert, Peter A 2nd

Peter Allen Dysert II, MD: a conversation with the editor. Interview by William Clifford Roberts

彼得·艾伦·戴瑟特二世医学博士:与编辑的对话。采访者:威廉·克利福德·罗伯茨

Dysert, Peter Allen 2nd

Diagnostic molecular pathology: current techniques and clinical applications, part I

诊断分子病理学:当前技术及临床应用(第一部分)

Netto, George J; Saad, Rana D; Dysert, Peter A 2nd